We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFACW
476
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$4.16K ﹤0.01%
75,593
-106,064
-58% -$6.29K
ENTFW
477
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Warrant
ENTFW
$4.07K ﹤0.01%
74,000
-100
-0.1% -$6
FTIIW
478
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$4.01K ﹤0.01%
44,663
+213
+0.5% +$9
ECDAW
479
DELISTED
ECD Automotive Design Warrant
ECDAW
$4K ﹤0.01%
100,147
+547
+0.5% +$20
ADEX.WS
480
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$4K ﹤0.01%
+50,000
New +$3.63K
MLECW icon
481
Moolec Science SA Warrant
MLECW
$180K
$4K ﹤0.01%
+50,000
New +$4.34K
PEGRW
482
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$3.97K ﹤0.01%
59,800
-200
-0.3% -$14
SPECW
483
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$3.96K ﹤0.01%
37,500
BURU.WS
484
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$3.88K ﹤0.01%
116,129
-188,916
-62% -$9.43K
DISTW
485
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$3.84K ﹤0.01%
130,150
-100
-0.1% -$3
HAIAW
486
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
$3.83K ﹤0.01%
43,721
-6,473
-13% -$399
ZLSWW
487
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$3.82K ﹤0.01%
96,116
+29,450
+44% +$975
PNACW
488
DELISTED
Prime Number Acquisition I Corp. Warrant
PNACW
$3.7K ﹤0.01%
74,009
-65,532
-47% -$3K
VBOCW
489
DELISTED
Viscogliosi Brothers Acquisition Corp Warrant
VBOCW
$3.68K ﹤0.01%
106,901
+8,301
+8% +$359
OSI.WS
490
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$3.66K ﹤0.01%
33,900
-55,058
-62% -$7.58K
PEPLW
491
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$3.65K ﹤0.01%
180,963
+49,900
+38% +$2.69K
SWVLW icon
492
Swvl Holdings Corp Warrant
SWVLW
$3.65K ﹤0.01%
232,703
+3,333
+1% +$61
SBCWW
493
SBC Medical Group Warrants
SBCWW
$2.65M
$3.58K ﹤0.01%
60,193
-65,988
-52% -$3.1K
SHPWW
494
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$3.57K ﹤0.01%
353,221
CEROW
495
DELISTED
CERo Therapeutics Warrants
CEROW
$3.54K ﹤0.01%
58,000
APCA.WS
496
DELISTED
AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
APCA.WS
$3.48K ﹤0.01%
63,598
-1,402
-2% -$92
SDSTW
497
Stardust Power Inc Warrant
SDSTW
$3.46K ﹤0.01%
98,900
-1,100
-1% -$62
DOMA.WS
498
DELISTED
Doma Holdings, Inc. Warrants, Every 25 warrants will be exercisable for one share of Common Stock at an exercise price of $287.50 per share of Common Stock
DOMA.WS
$3.39K ﹤0.01%
201,787
+100
+0% +$2
STLNW
499
Starling Oncology, Inc. Warrant
STLNW
$4.99M
$3.36K ﹤0.01%
120,600
+300
+0.2% +$17
FAASW
500
DELISTED
DigiAsia Corp Warrant
FAASW
$3.31K ﹤0.01%
110,710
-29,042
-21% -$1.24K

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.